Business Context and Reporting Period
This Form 8-K is a current report filed by Omeros Corp on June 14, 2012, regarding corporate governance changes. The company is incorporated in Washington and operates from Seattle.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and contains no financial data.
Material Changes
The material change reported is the resignation of Daniel K. Spiegelman from the Board of Directors. His resignation became effective on June 21, 2012.
Management Commentary and Risks
Mr. Spiegelman resigned in connection with his appointment as Chief Financial Officer of another publicly traded biopharmaceutical company. No other risks, contingencies, guidance, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Confirm the effective date of Daniel K. Spiegelman's resignation (June 21, 2012).
- Verify if the Board of Directors has appointed a replacement director.
- Review subsequent filings for any impact on the company's financial reporting or strategic direction.